This paper is in the following e-collection/theme issue:

Reviews on Innovations in Cancer (27) Digital Health Reviews (1191) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1573) Innovations and Technology in Cancer Care (405)

Published on in Vol 8, No 3 (2022): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39068, first published .
Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review

Authors of this article:

Matthew Lyall1 Author Orcid Image ;   Rebecca Crawford1 Author Orcid Image ;   Timothy Bell2 Author Orcid Image ;   Carla Mamolo3 Author Orcid Image ;   Alexander Neuhof4 Author Orcid Image ;   Courtney Levy1 Author Orcid Image ;   Anne Heyes1 Author Orcid Image
Article Authors Cited by (3) Tweetations (5) Metrics

Journals

  1. Midha S, Hartley-Brown M, Mo C, Hossain S, Nadeem O, O’Donnell E, Bianchi G, Sperling A, Laubach J, Richardson P. A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma. Expert Opinion on Drug Safety 2023;22(11):1049 View
  2. Hansen D, Bixby T, Fixler K, Shea L, Brittle C, Brunisholz K, Liu Y, Huo J. Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective. Journal of Patient Experience 2023;10 View
  3. Peña C, Graffigna P, Russo M, Forray E, Bustamante P. Improved overall survival of transplant eligible newly diagnosed multiple myeloma patients in a Chilean public center. How did we achieve it?. Hematology, Transfusion and Cell Therapy 2024 View